These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38214418)

  • 21. Exploiting the tumor immune microenvironment and immunometabolism using mitochondria-targeted drugs: Challenges and opportunities in racial disparity and cancer outcome research.
    Kalyanaraman B
    FASEB J; 2022 Apr; 36(4):e22226. PubMed ID: 35233843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SIRT3 aggravates metformin-induced energy stress and apoptosis in ovarian cancer cells.
    Wu Y; Gao WN; Xue YN; Zhang LC; Zhang JJ; Lu SY; Yan XY; Yu HM; Su J; Sun LK
    Exp Cell Res; 2018 Jun; 367(2):137-149. PubMed ID: 29580688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting respiratory complex I to prevent the Warburg effect.
    Vatrinet R; Iommarini L; Kurelac I; De Luise M; Gasparre G; Porcelli AM
    Int J Biochem Cell Biol; 2015 Jun; 63():41-5. PubMed ID: 25668477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining p53 stabilizers with metformin induces synergistic apoptosis through regulation of energy metabolism in castration-resistant prostate cancer.
    Chen L; Ahmad N; Liu X
    Cell Cycle; 2016; 15(6):840-9. PubMed ID: 26900800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glibenclamide Mimics Metabolic Effects of Metformin in H9c2 Cells.
    Salani B; Ravera S; Fabbi P; Garibaldi S; Passalacqua M; Brunelli C; Maggi D; Cordera R; Ameri P
    Cell Physiol Biochem; 2017; 43(3):879-890. PubMed ID: 28954268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin.
    Dalva-Aydemir S; Bajpai R; Martinez M; Adekola KU; Kandela I; Wei C; Singhal S; Koblinski JE; Raje NS; Rosen ST; Shanmugam M
    Clin Cancer Res; 2015 Mar; 21(5):1161-71. PubMed ID: 25542900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological and metabolic effects of IACS-010759, an OxPhos inhibitor, on chronic lymphocytic leukemia cells.
    Vangapandu HV; Alston B; Morse J; Ayres ML; Wierda WG; Keating MJ; Marszalek JR; Gandhi V
    Oncotarget; 2018 May; 9(38):24980-24991. PubMed ID: 29861847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in metformin‑based metabolic therapy for non‑small cell lung cancer (Review).
    Chen N; Zhou YS; Wang LC; Huang JB
    Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35039878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Energy metabolism modulation by biguanides in comparison with rotenone in rat liver and heart.
    Heinz S; Freyberger A; Lawrenz B; Schladt L; Schmuck G; Ellinger-Ziegelbauer H
    Arch Toxicol; 2019 Sep; 93(9):2603-2615. PubMed ID: 31324951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity.
    Chen D; Barsoumian HB; Fischer G; Yang L; Verma V; Younes AI; Hu Y; Masropour F; Klein K; Vellano C; Marszalek J; Davies M; Cortez MA; Welsh J
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial targets of metformin-Are they physiologically relevant?
    Pecinová A; Brázdová A; Drahota Z; Houštěk J; Mráček T
    Biofactors; 2019 Sep; 45(5):703-711. PubMed ID: 31343786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial Elongation and ROS-Mediated Apoptosis in Prostate Cancer Cells under Therapy with Apalutamide and Complex I Inhibitor.
    Baumgartner V; Schaer D; Moch H; Salemi S; Eberli D
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin in Oncology - How Far Is Its Repurposing as an Anticancer Drug?
    Pácal L; Kaňková K
    Klin Onkol; 2020; 33(2):107-113. PubMed ID: 32303131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of oxidative phosphorylation augments antineoplastic activity of mitotic aurora kinase inhibition.
    Zhang Z; Zeng D; Zhang W; Chen A; Lei J; Liu F; Deng B; Zhuo J; He B; Yan M; Lei X; Wang S; Lam EW; Liu Q; Wang Z
    Cell Death Dis; 2021 Sep; 12(10):893. PubMed ID: 34593753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate cancer cells survive anti-androgen and mitochondrial metabolic inhibitors by modulating glycolysis and mitochondrial metabolic activities.
    Basu HS; Wilganowski N; Robertson S; Reuben JM; Cohen EN; Zurita A; Ramachandran S; Xiao LC; Titus M; Wilding G
    Prostate; 2021 Sep; 81(12):799-811. PubMed ID: 34170017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modified Metformin as a More Potent Anticancer Drug: Mitochondrial Inhibition, Redox Signaling, Antiproliferative Effects and Future EPR Studies.
    Kalyanaraman B; Cheng G; Hardy M; Ouari O; Sikora A; Zielonka J; Dwinell MB
    Cell Biochem Biophys; 2017 Dec; 75(3-4):311-317. PubMed ID: 28429253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticancer mechanisms of metformin: A review of the current evidence.
    Zhao B; Luo J; Yu T; Zhou L; Lv H; Shang P
    Life Sci; 2020 Aug; 254():117717. PubMed ID: 32339541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin Inhibits Progression of Head and Neck Squamous Cell Carcinoma by Acting Directly on Carcinoma-Initiating Cells.
    Wu X; Yeerna H; Goto Y; Ando T; Wu VH; Zhang X; Wang Z; Amornphimoltham P; Murphy AN; Tamayo P; Chen Q; Lippman SM; Gutkind JS
    Cancer Res; 2019 Sep; 79(17):4360-4370. PubMed ID: 31292160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Petasin potently inhibits mitochondrial complex I-based metabolism that supports tumor growth and metastasis.
    Heishima K; Sugito N; Soga T; Nishikawa M; Ito Y; Honda R; Kuranaga Y; Sakai H; Ito R; Nakagawa T; Ueda H; Akao Y
    J Clin Invest; 2021 Sep; 131(17):. PubMed ID: 34623325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin as an Anticancer Agent.
    Vancura A; Bu P; Bhagwat M; Zeng J; Vancurova I
    Trends Pharmacol Sci; 2018 Oct; 39(10):867-878. PubMed ID: 30150001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.